国家卫生健康委近日会同市场监管总局发布了32项食品安全国家标准和2项标准修改单，其中，新修订 的《食品安全国家标准 保健食品良好生产规范》（GB 17405-2025）是保健食品生产规范自1998年发布 后，27年来首次更新。作为强制性国家标准，也是保健食品注册和备案管理、生产许可审查、生产企业 监督检查中食品安全管理的基础文件，新标准针对保健食品的特殊性，以《食品安全国家标准 食品生 产通用卫生规范》（GB 14881）框架为基础，充分考虑现行保健食品监管要求，突出保健食品生产过 程的原则性、通用性要求，进一步明确细化规定了保健食品生产的相关安全要求和管理准则。新标准要 求，相关技术指标需与保健食品注册或备案相关技术要求一致，便于企业执行，并衔接保健食品监管要 求。 强化保健食品的食品属性 依据相关规定，保健食品剂型形态主要包括片剂、粉剂、颗粒剂、硬胶囊剂、软胶囊剂、口服液、丸 剂、膏剂、酒剂、茶剂等剂型，以及饮料、饼干类、糖果类、糕点类、液体乳类等食品形态。此外，在 已获批准注册的保健食品中，还有滴剂、奶粉类、醋类、果冻类、粥类等少量其他剂型形态。 保健食品剂型形态多样，不同剂型形态生产情况差异较大。且随 ...

10月15日，金达威涨7.92%，成交额4.66亿元。两融数据显示，当日金达威获融资买入额5424.05万元， 融资偿还3515.29万元，融资净买入1908.76万元。截至10月15日，金达威融资融券余额合计4.39亿元。 融资方面，金达威当日融资买入5424.05万元。当前融资余额4.38亿元，占流通市值的3.38%，融资余额 超过近一年60%分位水平，处于较高位。 截至6月30日，金达威股东户数4.07万，较上期减少4.30%；人均流通股14976股，较上期增加4.50%。 2025年1月-6月，金达威实现营业收入17.28亿元，同比增长13.46%；归母净利润2.47亿元，同比增长 90.12%。 分红方面，金达威A股上市后累计派现27.61亿元。近三年，累计派现4.88亿元。 机构持仓方面，截止2025年6月30日，金达威十大流通股东中，香港中央结算有限公司位居第四大流通 股东，持股693.72万股，相比上期增加159.15万股。南方中证1000ETF（512100）位居第五大流通股 东，持股281.29万股，相比上期增加52.15万股。华夏中证1000ETF（159845）位居第九大流通股东，持 ...

天眼查App显示，近日，东莞市参阳力保健食品有限公司成立，注册资本50万人民币，经营范围为一般 项目：保健食品（预包装）销售；食品销售（仅销售预包装食品）；食品互联网销售（仅销售预包装食 品）；以自有资金从事投资活动；生产线管理服务；供冷服务；销售代理；木炭、薪柴销售；皮革销 售；电动自行车销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；水产品批 发；水产品零售；食用农产品批发；食用农产品初加工；食用农产品零售；农副产品销售；初级农产品 收购；专用化学产品销售（不含危险化学品）；非食用农产品初加工；林产品采集；商业、饮食、服务 专用设备销售；可可豆种植；咖啡豆种植；货物进出口；技术进出口。（除依法须经批准的项目外，凭 营业执照依法自主开展经营活动）许可项目：保健食品生产；食品销售；食品生产；食品小作坊经营； 食品互联网销售；餐饮服务；饮料生产；酒类经营；茶叶制品生产。（依法须经批准的项目，经相关部 门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

相关附件 | | 表一：食品监督抽检合格产品信息 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 声明：以下信息仅指本次抽检标称的生产企业相关产品的生产日期/批号和所检项目 | | | | | | | | 序 | 标称生产企业名称 | 标称生产企业地址 | 被抽样单位名称 | 被抽样单 位所在省 | 食品名称 | 规格型号 | 生产日 期/批 分类 | 备 | | 号 | | | | | | | | 注 | | | | | | 份 | | | 号 | | | 1 | / | / | 上海市青浦区华新镇曙 远蔬菜经营部 | 上海 | 胡萝卜 | / | 2025- 08-30 食用农产品 | | | 2 | 江苏亿口佳食品有 | 无锡市滨湖区胡埭镇杜鹃西路3- | 上海市青浦区赞八杂货 | 上海 | 炭烧腰果（分装） （炒货食品及坚果制 | 散装称重 | 2025- 炒货食品及 | | | | 限公司 | 1号 | 店 | | 品） | | 08-19 坚果制品 | | | 3 | 龙口市裕达食品有 | ...

Core Viewpoint - The newly revised "National Food Safety Standard for Good Manufacturing Practices of Health Food" (GB 17405-2025) has been officially released, marking the first update in 27 years, introducing stricter and more detailed requirements for health food production [1][2][3]. Group 1: Key Changes in the New Standard - The new standard expands from 10 chapters to 14 chapters, adding informative appendices and significantly revising various aspects such as site selection, factory environment, facilities, raw materials, and production process safety controls [1][2]. - The terminology has been updated to reflect food attributes more accurately, changing "general production area" and "clean area" to "general operation area" and "clean operation area" [2]. Group 2: Implementation and Impact - The implementation of the new standard aims to enhance production processes, ensure corporate responsibility, and improve product quality, thereby fostering innovation within the health food industry [3][4]. - The standard establishes a comprehensive control system covering the entire production chain from raw materials to finished products, enhancing safety measures and management requirements [4][5]. Group 3: Industry Implications - The new standard raises industry entry barriers, compelling companies to strengthen their quality management systems, while providing clear production guidelines for compliant enterprises [6]. - For consumers, the new standard is expected to enhance safety assurance in health food products, ensuring that consumers can purchase and consume these products with confidence [6].

9月25日，国家卫生健康委与国家市场监督管理总局联合修订的《食品安全国家标准保健食品良好生产 规范》（以下简称《生产规范》）（GB 17405—2025）正式发布。这是标准继1998年出台后，27年来 首次更新。这项强制性国家标准针对保健食品生产的各个环节提出了更为严格、细致的要求。新标准与 修订前相比内容调整较大，标准文本从原先的10个章节增加到14个章节，并增加了资料性附录。《生产 规范》对原标准中选址及厂区环境、厂房和车间、设施与设备、保健食品原料、辅料及食品相关产品、 生产过程的食品安全控制、验证和检验要求等多项内容进行修订，增加食品安全管理、产品召回及追溯 管理要求及不同类别保健食品作业区划分指南。 《生产规范》的发布，进一步贯彻落实"最严谨的标准"要求，一方面，保持与GB 14881的协同性，有 助于规范保健食品生产企业生产流程，落实企业主体责任，贴合保健食品生产企业实际需求，提升生产 效率与产品质量，激发企业创新活力与内生动力；另一方面，有助于完善特殊食品标准体系，强化特殊 食品安全基础标准供给，将标准与保健食品监管原则紧密衔接，构建起更为完善的监管链条，为行业健 康发展提供技术支撑。 "食品安 ...

Core Viewpoint - The newly revised "National Food Safety Standard for Good Manufacturing Practices of Health Food" (GB 17405—2025) has been officially released, marking the first update in 27 years since its initial introduction in 1998. The new standard imposes stricter and more detailed requirements across all production stages of health food [1][5]. Group 1: Key Changes in the Standard - The new standard has expanded from 10 chapters to 14 chapters, including additional informative appendices [1]. - Significant revisions have been made to various aspects such as site selection, factory environment, facilities and equipment, raw materials, production processes, and food safety control measures [4][6]. - The terminology has shifted from "general production area" and "clean area" to "general operation area" and "clean operation area," aligning with food-related expressions [4]. Group 2: Implementation and Impact - The release of the new standard aims to enhance the production processes of health food companies, ensuring compliance with the most rigorous standards and improving product quality and safety [5][7]. - The standard establishes a comprehensive control system from raw materials to finished products, enhancing safety measures throughout the production chain [6]. - The introduction of a "verification" chapter solidifies product safety and ensures that the entire production process is controllable [7]. Group 3: Industry Implications - The new standard raises the entry barriers for the health food industry, compelling companies to strengthen their quality management systems [7]. - It provides clear production guidelines for compliant companies, fostering healthy competition within the industry [7]. - Consumers will benefit from enhanced safety assurances, allowing them to purchase and consume health food products with greater confidence [7].

（编辑 王雪儿） 证券日报网讯 汤臣倍健9月25日在互动平台回答投资者提问时表示，公司严格遵循《广告法》对保健食 品的相关规定，旗下保健食品未聘请广告代言人进行推荐或证明。公司坚持强品牌战略，积极推动长效 品牌建设，持续打造"专业、有生命活力"的品牌心智，赋能业务有质量增长。 ...

Core Insights - The Chinese health food industry is experiencing a structural transformation characterized by "inventory reshuffling and weakened growth," moving away from the era of broad-based growth due to regulatory upgrades and evolving consumer concepts [2][10] Industry Overview - In the first half of 2025, the online market for health food reached a sales figure of 60.41 billion yuan, with a year-on-year growth rate of 16.2%, indicating the sector's competitive intensity [2] - Major companies are facing declining revenues, with inventory turnover days increasing, signaling a challenging environment for traditional growth models [2][10] Company Performance - The vitality ranking of health food companies shows significant performance disparities, with innovative companies gaining a premium [4][5] - Key players like健合集团 reported a revenue of 7.02 billion yuan, with a 71.7% increase in revenue from emerging Asian markets, highlighting successful global strategies [5] - 仙乐健康, a leading CDMO, achieved a revenue of 2.042 billion yuan (+2.57%), with a remarkable 200% growth in private traffic contributing to its success [7] - 汤臣倍健's second-quarter net profit grew by 71.4%, indicating effective inventory management and operational efficiency [9] Market Trends - The health food sector is witnessing structural growth, with significant differentiation in performance across companies and product categories [5] - Categories such as cardiovascular health (37.4% growth), bone health (34.9% growth), and women's health (26.0% growth) are emerging as key growth drivers [10] - The shift towards new consumption channels, including live streaming and private domains, is becoming crucial for enhancing customer loyalty and combating rising public traffic costs [10][13] Future Outlook - The industry is expected to continue its trend of differentiation, with a focus on precision, technology, and globalization as core competitive strategies [10][12] - Companies are encouraged to explore overseas markets, particularly in Southeast Asia and Latin America, to leverage demographic advantages and growth potential [13] - The competition is entering a new phase centered on quality improvement, with long-term strategic focus and technological accumulation being vital for success [13]

Company Overview - Yong'an Pharmaceutical (SZ 002365) announced a temporary board meeting on September 24, 2025, to review the proposal for revising the "Board Audit Committee Work System" [1] - As of the report, Yong'an Pharmaceutical has a market capitalization of 5.2 billion yuan [1] Revenue Composition - For the first half of 2025, Yong'an Pharmaceutical's revenue composition is as follows: - Pharmaceutical manufacturing accounts for 64.14% - Health food accounts for 24.67% - Chemical manufacturing accounts for 10.88% - Other businesses account for 0.32% [1]